跳到正文
原文
Endpoints News 生物医药· Max Bayer·· 18 天前AI 评分20

AbbVie 与 Brise Pharma 合作开发两款治疗偏头痛的在研药物

AbbVie, Brise disclose deal for two preclinical migraine meds

AI 导读

AbbVie 已与北京的 Brise Pharma 达成一项发现和商业化合作,涉及两款处于临床前阶段的偏头痛治疗药物。

正文

Ab­b­Vie has agreed to a dis­cov­ery and com­mer­cial­iza­tion deal with Brise Phar­ma for two pre­clin­i­cal mi­graine pro­grams.

The Bei­jing-based part­ner

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news